Appetite suppression intensifies as your dose gradually increases over the first 48 weeks
Expert Opinion GLP-1 receptor agonists, along with dual and triple agonists, have transformed the landscape of adolescent obesity treatment, offering an effective alternative to lifestyle interventions that often fail to produce long-term results
Youll have access to provider oversight, nutrition guidance, fitness support, and a care team you can message when questions come up
Rather than assuming all patients respond identically to standard 2.5 mg dosing, understanding your genetic context and metabolic baseline can support a more informed conversation about your personalized escalation timeline, expected response window, and long-term dosing strategy
Six months gives you enough time to answer those questions honestly
Diagnostic criteria for primary autoimmune cerebellar ataxia guidelines from an international task force on immune-mediated cerebellar ataxias